FDA Approved Medical Products for:

Myelodysplastic/myeloproliferative disease

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Imatinib mesylate
Trade Name
(Manufacturer Name)
Gleevec®
(Novartis Pharmaceuticals Corp.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor)
More Information about this product Drug Information Portal